Bio-Techne Corp (TECH)

Nasdaq: TECH · Biological Products, (No Diagnostic Substances) · Minneapolis, MN · filing with the SEC since 1995

Grade6.3

◀ Past 7.2● Present 7.3▶ Future 4.2

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in June.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Report filed	Aug 24, 2026	Aug 22, 2025	Aug 22, 2024	Aug 23, 2023	Aug 24, 2022	Aug 25, 2021	Aug 26, 2020	Aug 28, 2019	Aug 27, 2018	Sep 7, 2017
Revenue	1,215,039	1,219,635	1,159,060	1,136,702	1,105,599	931,032	738,691	714,006	642,993	563,003
Cost of revenue	415,968	429,363	389,335	366,887	349,103	298,182	255,497	240,515	210,850	188,462
Gross profit	799,071	790,272	769,725	769,815	756,496	632,850	483,194	473,491	432,143	374,541
Research and development	94,766	99,496	96,664	92,493	87,140	70,603	65,192	62,413	55,329	53,514
Selling, general and administrative	452,415	588,521	466,375	378,378	372,766	324,951	260,583	264,359	240,636	200,443
Total operating expenses	547,181	688,017	563,039	470,871	459,906	395,554	325,775	326,772	295,965	253,957
Operating income	251,890	102,255	206,686	298,944	296,590	237,296	157,419	146,719	136,178	120,584
Interest expense	9,630	8,509	15,736	11,215	11,309	13,952	19,197	21,705	10,188	7,361
Interest and investment income	4,223	3,886	3,323	3,410	794	473	605	569	409	304
Share of profit of equity-method investments	887	938	-6,841	-1,143	·	·	·	·	·	·
Other income (expense), net	-5,803	831	-8,584	47,520	15,311	-75,642	137,650	-13,568	-447	-1,566
Total non-operating income (expense)	-11,210	-3,792	-20,997	39,715	4,796	-89,121	119,058	-34,704	-10,226	-8,623
Income before income taxes	240,680	98,463	185,689	338,659	301,386	148,175	276,477	112,015	125,952	111,961
Income tax expense	58,818	25,063	17,584	53,217	38,287	8,590	47,181	15,943^r	-198	35,875
Net income including non-controlling interests	181,862	73,400	168,105	285,442	263,099	139,585	229,296	96,072	·	·
Net income to non-controlling interests	·	·	·	179	-8,952	-825	0	0	·	·
Net income	·	73,400	168,105	285,263	272,051	140,410	229,296	96,072	126,150	76,086
Net income to common shareholders	181,840	73,363	168,072	285,193	271,930	140,324	229,072	95,967	126,042	76,021
Earnings per share, basic	1.17	0.47	1.07	1.81	1.73^r	0.91^r	1.50^b	0.635^b	0.84^b	0.51^b
Earnings per share, diluted	1.16	0.46	1.05	1.76	1.66^r	0.87^r	1.455^b	0.6175^b	0.8275^b	0.5075^b
Weighted average shares, basic	155,963	157,521	157,708	157,179	156,874^r	154,986^r	152,804^b	151,124^b	149,904^b	149,252^b
Weighted average shares, diluted	157,009	159,717	160,774	161,855	164,114^r	161,932^r	157,604^b	155,568^b	152,220^b	150,000^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 4-for-1 split of Nov 2022.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueNet

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earned

us-gaap:InvestmentIncomeNet
us-gaap:InvestmentIncomeInterestAndDividend

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton TECH · research, not advice